Fujian Cosunter Pharmaceutical (300436.SZ) Earnings Analysis

Fujian Cosunter Pharmaceutical (300436.SZ) has no confirmed upcoming earnings date. Trailing P/E -65.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300436.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300436.SZ. This page updates as the calendar is published.

300436.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-09-29-0.28189 CNYn/an/an/a
2025-06-30-0.23988 CNYn/an/an/a
2025-03-31-0.1789 CNYn/an/an/a
2024-09-28-0.21726 CNYn/an/an/a

300436.SZ valuation and analyst view

Trailing P/E-65.84
Trailing EPS-1.35194 CNY
Price / book56.25
Dividend yield0.00%
Market cap14.55B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Fujian Cosunter Pharmaceutical (300436.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300436.SZ. This page updates as the calendar is published.

Did 300436.SZ beat earnings last quarter?

Consensus estimate data was not available for 300436.SZ's 2025-09-29 report.

What is 300436.SZ's current P/E ratio and EPS?

300436.SZ trades at a trailing P/E of -65.84 on trailing EPS of -1.3519437604053364 CNY.

What do analysts rate 300436.SZ?

300436.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.